ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, announced today that it has entered an agreement with Public University Corporation Yokohama City University (YCU) to review a Pseudomonas aeruginosa vaccine, with an exclusive option to license the technology.

Halifax-based Green Power Labs Inc., a leading Canadian solar energy assessment and consulting firm, has announced a new partnership agreement with CHELONIA SA, based in Lugano, Switzerland.

EastMed Inc., the medical manufacturing company responsible for the uresta® Continence Care kit, welcomes Superior Medical as its Canadian distribution partner.

The staff and clients of Innovacorp would like to welcome our newest client, Carbon Sense Solutions Inc.

The staff and clients at Innovacorp would like to welcome Prescribed Solutions Inc.

The cost of prescription drugs continues to rise at an alarming pace, resulting in substantial increases to health benefit plans.Benefit premiums are growing, co-payments are increasing, and restrictions to therapeutic options are climbing. Add to this an aging population, and sustaining a prescription drug benefit plan will become even more challenging.

ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, has announced the signing of a 3-year research agreement with Defence Research and Development Canada (DRDC). The research collaboration involves the preclinical application of IVT’s DepoVax™ vaccine formulation to anthrax antigens to explore new methods to prevent, prepare for, and respond to biological  threats.

Innovacorp has been named one of two finalists for the National Business Incubation Association's 2009 international award for work with start-up businesses.

Stack-A-Buoy Marine Products Limited, a Cape Breton-based marine floatation products company, will officially launch its innovative new product February 27, 2009, at the Eastern Canadian Fisheries Exhibition in Yarmouth, Nova Scotia.

The Globe and Mail’s Report on Business has a new feature series called The Breakthrough. Each week, The Breakthrough examines a small business that has experienced a significant turning point in its history and includes a related online Q&A with an expert. Innovacorp’s president and CEO, Dan MacDonald, was asked to be the expert for a February feature about Montreal-based company La Fourmi Bionique, which recently experienced a breakthrough of having Le Chateau’s founder invest in the company, allowing it to widen its distribution beyond Quebec and go for some other milestones.

The staff and clients of Innovacorp welcome our newest client, GOALLINE.